What You Should Know:
– SpotitEarly, a biotech company pioneering a non-invasive approach to early cancer detection, has officially launched its U.S. operations following a $20.3 million funding round.
– The company aims to revolutionize cancer screening…
Continue Reading
What You Should Know:
– Function Health is acquiring Ezra — to launch the first FDA-cleared, AI-powered Full Body MRI scan that takes just 22 minutes instead of 45, and costs $499 instead of over $1,500.
– This dramatic reduction…
Continue Reading
Breakthrough AI Innovations Transform Breast Care
GE HealthCare is showcasing its cutting-edge advancements in diagnostic accuracy and patient-centered breast care at the 2025 Society of Breast Imaging Symposium in Colorado Springs, Colorado (April 24-27, 2025)….
Study Confirms AI Boosts Cancer Detection Rates
Lunit’s groundbreaking research published in Nature Communications has validated the effectiveness of AI-powered mammography screening in real-world settings. This first-of-its-kind large-scale, multicenter prospective study demonstrated that AI assistance…
Revolutionary Findings in Breast Cancer Screening
A landmark clinical trial has revolutionized breast cancer screening by demonstrating the remarkable effectiveness of artificial intelligence in mammography. The Mammography Screening with Artificial Intelligence (MASAI) trial, published in…
Vik Bajaj, managing director at venture capitalist firm Foresite Capital, which focuses on transforming healthcare through data-driven solutions, sat down with MobiHealthNews to discuss President Trump’s recently announced $500 billion Project Stargate and AI’s…
Continue Reading
Key Medical Discoveries Through ISS Research
SpaceX’s 31st Commercial Resupply Services mission to the International Space Station (ISS) has brought groundbreaking biotechnology research possibilities. The mission carried approximately 50 research payloads, focusing on advancing medical…
What You Should Know:
– C the Signs, a developer of AI-powered cancer detection solutions, today announced an $8 million funding round led by Khosla Ventures.
– The investment will fuel the company’s expansion from the…
Continue Reading
Research conducted on the International Space Station (ISS) may result in early cancer detection, advance treatments for neurodegenerative conditions and improve respiratory therapies.Space Station (ISS) on SpaceX’s 31st Commercial Resupply Services (CRS) was on…
Continue Reading
Strategic Acquisition Enhances AI Capabilities
ScreenPoint Medical’s acquisition of Biomediq A/S on January 8, 2025, represents a milestone in AI-driven breast cancer detection. This strategic merger follows ten years of collaborative research, integrating Biomediq’s quantitative…
